| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/HYPERTENSIONAHA.114.03194 |
| P698 | PubMed publication ID | 24664290 |
| P50 | author | Ondrej Petrak | Q61829856 |
| Jan A. Staessen | Q37390604 | ||
| Grégoire Wuerzner | Q38327073 | ||
| Patrick B Mark | Q40845114 | ||
| Sverre E. Kjeldsen | Q45903512 | ||
| Alexandre Persu | Q56245924 | ||
| Danuta Czarnecka | Q58326245 | ||
| P2093 | author name string | Michel Burnier | |
| Michiel L Bots | |||
| Wilko Spiering | |||
| Georg Ehret | |||
| Bernhard Schmidt | |||
| Yu Jin | |||
| Peter J Blankestijn | |||
| Alison Taylor | |||
| Antoinette Pechère-Bertschi | |||
| Jan Menne | |||
| Jean Renkin | |||
| Thomas Kahan | |||
| Lotte Jacobs | |||
| Michael H Olsen | |||
| Fadl Elmula M Fadl Elmula | |||
| Jan Rosa | |||
| European Network Coordinating research on REnal Denervation Consortium | |||
| Eva Vink | |||
| Fadi Jokhaji | |||
| Francesca Severino | |||
| Jiři Widimsky | |||
| Marie Baelen | |||
| Marie K Blicher | |||
| Willemien L Verloop | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1319-1325 | |
| P577 | publication date | 2014-03-24 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Eligibility for renal denervation: experience at 11 European expert centers | |
| P478 | volume | 63 |
| Q38632012 | A perspective on sympathetic renal denervation in chronic congestive heart failure |
| Q59347448 | Adherence to Medications in Uncontrolled Hypertension |
| Q38686369 | Adherence to medication and drug monitoring in apparent treatment-resistant hypertension |
| Q39081841 | Apparent treatment-resistant hypertension - patient-physician relationship and ethical issues |
| Q58717778 | Arterial Hypertension |
| Q88524953 | Cardiovascular morbidity of severe resistant hypertension among treated uncontrolled hypertensives: a 4-year follow-up study |
| Q26745306 | Chronic Kidney Disease As a Potential Indication for Renal Denervation |
| Q28659099 | Con: renal denervation for all resistant hypertensive patients: the Emperor's new clothes |
| Q53720562 | Flow-mediated dilation, nitroglycerin-mediated dilation and their ratio predict successful renal denervation in mild resistant hypertension. |
| Q87993964 | Focus on blood pressure as a major risk factor |
| Q35611525 | Global- and renal-specific sympathoinhibition in aldosterone hypertension |
| Q64927585 | Guest Editorial Challenges in Resistant Hypertension. |
| Q64987290 | Hypertension in Chronic Kidney Disease - Role of Arterial Calcification and Impact on Treatment. |
| Q34449964 | Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension |
| Q53632976 | Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. |
| Q47107898 | Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform |
| Q90911199 | Rapid treatment of moderate to severe hypertension using a novel protocol in a single-centre, before and after interventional study |
| Q92219063 | Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence |
| Q40303410 | Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiography |
| Q34006930 | Renal denervation after Symplicity HTN-3: an update |
| Q36122797 | Renal denervation for the treatment of resistant hypertension: review and clinical perspective |
| Q42422915 | Renal denervation: are we at a crossroads? |
| Q86025485 | Renal nerve stimulation to predict responders to renal denervation |
| Q28084016 | Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension |
| Q47730220 | Renal sympathetic denervation in the aftermath of Symplicity HTN-3. |
| Q38818684 | Renal vascular calcification and response to renal nerve denervation in resistant hypertension |
| Q39308306 | Resistant Hypertension: An Update of Experimental and Clinical Findings |
| Q36472001 | Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria |
| Q36869942 | Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation |
| Q36480001 | Sympathetic overactivity occurs before hypertension in the two-kidney, one-clip model. |
| Q47812598 | Tertiary work-up of apparent treatment-resistant hypertension |
Search more.